Viewing Study NCT00102505


Ignite Creation Date: 2025-12-25 @ 3:20 AM
Ignite Modification Date: 2026-05-23 @ 11:20 AM
Study NCT ID: NCT00102505
Status: COMPLETED
Last Update Posted: 2009-04-03
First Post: 2005-01-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC)
Sponsor: Pharmacyclics LLC.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Small-Cell Lung Carcinoma View
None Carcinoma, Bronchogenic View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-Small Cell Lung Cancer View
None Lung Cancer View
None Metastatic lung cancer View
None Inoperable lung cancer View
None Advanced lung cancer View
None Large-cell lung cancer View
None Adenocarcinoma, lung View
None Squamous cell carcinoma, lung View
None Squamous cell lung cancer View
None Large cell carcinoma, lung View
None Bronchogenic View